BUILDERS FIRSTSOURCE INC (BLDR) Stock Fundamental Analysis

NYSE:BLDR • US12008R1077

110.55 USD
-0.87 (-0.78%)
At close: Feb 20, 2026
110.55 USD
0 (0%)
After Hours: 2/20/2026, 8:18:59 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

Taking everything into account, BLDR scores 4 out of 10 in our fundamental rating. BLDR was compared to 42 industry peers in the Building Products industry. BLDR has only an average score on both its financial health and profitability. BLDR has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • BLDR had positive earnings in the past year.
  • BLDR had a positive operating cash flow in the past year.
  • Of the past 5 years BLDR 4 years were profitable.
  • Of the past 5 years BLDR 4 years had a positive operating cash flow.
BLDR Yearly Net Income VS EBIT VS OCF VS FCFBLDR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

1.2 Ratios

  • BLDR's Return On Assets of 5.20% is in line compared to the rest of the industry. BLDR outperforms 57.14% of its industry peers.
  • BLDR has a better Return On Equity (13.76%) than 69.05% of its industry peers.
  • BLDR's Return On Invested Capital of 8.34% is in line compared to the rest of the industry. BLDR outperforms 50.00% of its industry peers.
  • BLDR had an Average Return On Invested Capital over the past 3 years of 22.36%. This is significantly above the industry average of 11.95%.
  • The 3 year average ROIC (22.36%) for BLDR is well above the current ROIC(8.34%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 5.2%
ROE 13.76%
ROIC 8.34%
ROA(3y)16.93%
ROA(5y)14.89%
ROE(3y)37.68%
ROE(5y)35.24%
ROIC(3y)22.36%
ROIC(5y)20.5%
BLDR Yearly ROA, ROE, ROICBLDR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

  • BLDR has a Profit Margin of 3.79%. This is comparable to the rest of the industry: BLDR outperforms 42.86% of its industry peers.
  • BLDR's Profit Margin has improved in the last couple of years.
  • Looking at the Operating Margin, with a value of 6.57%, BLDR is doing worse than 61.90% of the companies in the same industry.
  • In the last couple of years the Operating Margin of BLDR has grown nicely.
  • BLDR has a Gross Margin of 30.97%. This is comparable to the rest of the industry: BLDR outperforms 52.38% of its industry peers.
  • In the last couple of years the Gross Margin of BLDR has grown nicely.
Industry RankSector Rank
OM 6.57%
PM (TTM) 3.79%
GM 30.97%
OM growth 3Y-6.99%
OM growth 5Y12.55%
PM growth 3Y-8.82%
PM growth 5Y16.6%
GM growth 3Y3.73%
GM growth 5Y3.86%
BLDR Yearly Profit, Operating, Gross MarginsBLDR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so BLDR is creating value.
  • There is no outstanding debt for BLDR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BLDR Yearly Shares OutstandingBLDR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
BLDR Yearly Total Debt VS Total AssetsBLDR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • BLDR has an Altman-Z score of 2.87. This is not the best score and indicates that BLDR is in the grey zone with still only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.87, BLDR is in line with its industry, outperforming 47.62% of the companies in the same industry.
  • The Debt to FCF ratio of BLDR is 4.35, which is a neutral value as it means it would take BLDR, 4.35 years of fcf income to pay off all of its debts.
  • BLDR has a Debt to FCF ratio of 4.35. This is comparable to the rest of the industry: BLDR outperforms 54.76% of its industry peers.
  • BLDR has a Debt/Equity ratio of 1.03. This is a high value indicating a heavy dependency on external financing.
  • BLDR's Debt to Equity ratio of 1.03 is on the low side compared to the rest of the industry. BLDR is outperformed by 73.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 4.35
Altman-Z 2.87
ROIC/WACC0.87
WACC9.54%
BLDR Yearly LT Debt VS Equity VS FCFBLDR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

  • A Current Ratio of 1.79 indicates that BLDR should not have too much problems paying its short term obligations.
  • BLDR has a Current ratio (1.79) which is comparable to the rest of the industry.
  • BLDR has a Quick Ratio of 1.15. This is a normal value and indicates that BLDR is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of BLDR (1.15) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.79
Quick Ratio 1.15
BLDR Yearly Current Assets VS Current LiabilitesBLDR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • BLDR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -40.24%.
  • BLDR shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 17.40% yearly.
EPS 1Y (TTM)-40.24%
EPS 3Y-28.14%
EPS 5Y17.4%
EPS Q2Q%-51.52%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2.37%

3.2 Future

  • The Earnings Per Share is expected to grow by 14.16% on average over the next years. This is quite good.
  • BLDR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.01% yearly.
EPS Next Y-11.26%
EPS Next 2Y7.34%
EPS Next 3Y14.16%
EPS Next 5YN/A
Revenue Next Year-0.62%
Revenue Next 2Y2.63%
Revenue Next 3Y4.01%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
BLDR Yearly Revenue VS EstimatesBLDR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B 20B
BLDR Yearly EPS VS EstimatesBLDR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 16.04, the valuation of BLDR can be described as correct.
  • Based on the Price/Earnings ratio, BLDR is valued a bit cheaper than the industry average as 69.05% of the companies are valued more expensively.
  • BLDR's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.99.
  • With a Price/Forward Earnings ratio of 18.08, BLDR is valued on the expensive side.
  • BLDR's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. BLDR is cheaper than 69.05% of the companies in the same industry.
  • BLDR is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 28.06, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.04
Fwd PE 18.08
BLDR Price Earnings VS Forward Price EarningsBLDR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 69.05% of the companies in the same industry are more expensive than BLDR, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of BLDR indicates a rather cheap valuation: BLDR is cheaper than 90.48% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 11.98
EV/EBITDA 10.26
BLDR Per share dataBLDR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

  • The decent profitability rating of BLDR may justify a higher PE ratio.
  • BLDR's earnings are expected to grow with 14.16% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)0.92
EPS Next 2Y7.34%
EPS Next 3Y14.16%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for BLDR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BUILDERS FIRSTSOURCE INC

NYSE:BLDR (2/20/2026, 8:18:59 PM)

After market: 110.55 0 (0%)

110.55

-0.87 (-0.78%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)02-17
Earnings (Next)04-29
Inst Owners104.69%
Inst Owner Change-2.76%
Ins Owners2.49%
Ins Owner Change0.09%
Market Cap12.22B
Revenue(TTM)N/A
Net Income(TTM)593.96M
Analysts71.33
Price Target133.9 (21.12%)
Short Float %4.19%
Short Ratio2.24
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.43%
Min EPS beat(2)2.38%
Max EPS beat(2)12.49%
EPS beat(4)4
Avg EPS beat(4)8.92%
Min EPS beat(4)2.38%
Max EPS beat(4)12.49%
EPS beat(8)8
Avg EPS beat(8)12.55%
EPS beat(12)12
Avg EPS beat(12)24.1%
EPS beat(16)16
Avg EPS beat(16)36.2%
Revenue beat(2)1
Avg Revenue beat(2)-1.32%
Min Revenue beat(2)-2.96%
Max Revenue beat(2)0.31%
Revenue beat(4)1
Avg Revenue beat(4)-5.53%
Min Revenue beat(4)-17.56%
Max Revenue beat(4)0.31%
Revenue beat(8)2
Avg Revenue beat(8)-3.83%
Revenue beat(12)5
Avg Revenue beat(12)-2.18%
Revenue beat(16)9
Avg Revenue beat(16)1.88%
PT rev (1m)-0.94%
PT rev (3m)-5.37%
EPS NQ rev (1m)-0.13%
EPS NQ rev (3m)-3.06%
EPS NY rev (1m)-1.33%
EPS NY rev (3m)-0.68%
Revenue NQ rev (1m)-0.2%
Revenue NQ rev (3m)-0.68%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)-0.15%
Valuation
Industry RankSector Rank
PE 16.04
Fwd PE 18.08
P/S 0.78
P/FCF 11.98
P/OCF 8.77
P/B 2.83
P/tB N/A
EV/EBITDA 10.26
EPS(TTM)6.89
EY6.23%
EPS(NY)6.11
Fwd EY5.53%
FCF(TTM)9.23
FCFY8.35%
OCF(TTM)12.61
OCFY11.41%
SpS141.55
BVpS39.03
TBVpS-7.92
PEG (NY)N/A
PEG (5Y)0.92
Graham Number77.79
Profitability
Industry RankSector Rank
ROA 5.2%
ROE 13.76%
ROCE 10.73%
ROIC 8.34%
ROICexc 8.6%
ROICexgc 19.5%
OM 6.57%
PM (TTM) 3.79%
GM 30.97%
FCFM 6.52%
ROA(3y)16.93%
ROA(5y)14.89%
ROE(3y)37.68%
ROE(5y)35.24%
ROIC(3y)22.36%
ROIC(5y)20.5%
ROICexc(3y)22.6%
ROICexc(5y)21.09%
ROICexgc(3y)52.47%
ROICexgc(5y)46.44%
ROCE(3y)28.8%
ROCE(5y)26.39%
ROICexgc growth 3Y-14.33%
ROICexgc growth 5Y9.79%
ROICexc growth 3Y-13.16%
ROICexc growth 5Y2.57%
OM growth 3Y-6.99%
OM growth 5Y12.55%
PM growth 3Y-8.82%
PM growth 5Y16.6%
GM growth 3Y3.73%
GM growth 5Y3.86%
F-Score5
Asset Turnover1.37
Health
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 4.35
Debt/EBITDA 2.76
Cap/Depr 64.9%
Cap/Sales 2.39%
Interest Coverage 4.4
Cash Conversion 86.87%
Profit Quality 171.79%
Current Ratio 1.79
Quick Ratio 1.15
Altman-Z 2.87
F-Score5
WACC9.54%
ROIC/WACC0.87
Cap/Depr(3y)73.83%
Cap/Depr(5y)71.85%
Cap/Sales(3y)2.2%
Cap/Sales(5y)1.81%
Profit Quality(3y)125.27%
Profit Quality(5y)102.16%
High Growth Momentum
Growth
EPS 1Y (TTM)-40.24%
EPS 3Y-28.14%
EPS 5Y17.4%
EPS Q2Q%-51.52%
EPS Next Y-11.26%
EPS Next 2Y7.34%
EPS Next 3Y14.16%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2.37%
Revenue Next Year-0.62%
Revenue Next 2Y2.63%
Revenue Next 3Y4.01%
Revenue Next 5YN/A
EBIT growth 1Y-42.25%
EBIT growth 3Y-12.79%
EBIT growth 5Y32.41%
EBIT Next Year1.94%
EBIT Next 3Y3.06%
EBIT Next 5Y5.19%
FCF growth 1Y-52.65%
FCF growth 3Y-0.52%
FCF growth 5Y30.71%
OCF growth 1Y-47.7%
OCF growth 3Y2.41%
OCF growth 5Y30.02%

BUILDERS FIRSTSOURCE INC / BLDR FAQ

Can you provide the ChartMill fundamental rating for BUILDERS FIRSTSOURCE INC?

ChartMill assigns a fundamental rating of 4 / 10 to BLDR.


What is the valuation status of BUILDERS FIRSTSOURCE INC (BLDR) stock?

ChartMill assigns a valuation rating of 5 / 10 to BUILDERS FIRSTSOURCE INC (BLDR). This can be considered as Fairly Valued.


Can you provide the profitability details for BUILDERS FIRSTSOURCE INC?

BUILDERS FIRSTSOURCE INC (BLDR) has a profitability rating of 6 / 10.


Can you provide the financial health for BLDR stock?

The financial health rating of BUILDERS FIRSTSOURCE INC (BLDR) is 4 / 10.


What is the earnings growth outlook for BUILDERS FIRSTSOURCE INC?

The Earnings per Share (EPS) of BUILDERS FIRSTSOURCE INC (BLDR) is expected to decline by -11.26% in the next year.